Repository logo
 
Publication

Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment

dc.contributor.authorCunha, Ludmylla
dc.contributor.authorRodrigues, Susana
dc.contributor.authorRosa Da Costa, Ana
dc.contributor.authorFaleiro, Maria Leonor
dc.contributor.authorButtini, Francesca
dc.contributor.authorGrenha, Ana
dc.date.accessioned2020-04-02T10:10:52Z
dc.date.available2020-08-01T00:30:11Z
dc.date.issued2019
dc.description.abstractThe direct delivery of antibiotics to the lung has been considered an effective approach to treat pulmonary tuberculosis, which represents approximately 80% of total cases. In this sense, this work aimed at producing inhalable chitosan microparticles simultaneously associating isoniazid and rifabutin, for an application in pulmonary tuberculosis therapy. Spray-dried chitosan microparticles were obtained with adequate flow properties for deep lung delivery (aerodynamic diameter of 4 µm) and high drug association efficiencies (93% for isoniazid and 99% for rifabutin). The highest concentration of microparticles that was tested (1 mg/mL) decreased the viability of macrophage-differentiated THP-1 cells to around 60% after 24 h exposure, although no deleterious effect was observed in human alveolar epithelial (A549) cells. The release of LDH was, however, increased in both cells. Chitosan microparticles further evidenced capacity to activate macrophage-like cells, inducing cytokine secretion well above basal levels. Moreover, the propensity of macrophages to internalize microparticles was demonstrated, with uptake levels over 90%. Chitosan microparticles also inhibited bacterial growth by 96%, demonstrating that the microencapsulation preserved drug antibacterial activity in vitro. Overall, the obtained data suggest the potential of chitosan microparticles for inhalable lung tuberculosis therapy.pt_PT
dc.description.sponsorshipPTDC/DTP-486 FTO/0094/2012pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1080/03639045.2019.1608231pt_PT
dc.identifier.issn0363-9045
dc.identifier.urihttp://hdl.handle.net/10400.1/13681
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherTaylor & Francispt_PT
dc.subjectA549 cellspt_PT
dc.subjectAdministrationpt_PT
dc.subjectAntitubercular agentspt_PT
dc.subjectCell Linept_PT
dc.subjectChitosanpt_PT
dc.subjectDrug carrierspt_PT
dc.subjectHumanspt_PT
dc.subjectIsoniazidpt_PT
dc.subjectLungpt_PT
dc.subjectMacrophagespt_PT
dc.subjectNanoparticlespt_PT
dc.subjectParticle sizept_PT
dc.subjectRifabutinpt_PT
dc.subjectTuberculosispt_PT
dc.subjectTumorpt_PT
dc.subjectAlveolarpt_PT
dc.subjectInhalationpt_PT
dc.subjectPulmonarypt_PT
dc.titleInhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatmentpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FMulti%2F04326%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FBIM%2F04773%2F2013/PT
oaire.citation.endPage1320pt_PT
oaire.citation.issue8pt_PT
oaire.citation.startPage1313pt_PT
oaire.citation.titleDrug Development and Industrial Pharmacypt_PT
oaire.citation.volume45pt_PT
oaire.fundingStream5876
oaire.fundingStream5876
person.familyNameCunha
person.familyNameRodrigues
person.familyNameRosa da Costa
person.familyNameFaleiro
person.familyNameGrenha
person.givenNameLudmylla Costa
person.givenNameSusana
person.givenNameAna M
person.givenNameMaria Leonor
person.givenNameAna
person.identifier305029
person.identifier252666
person.identifier.ciencia-id9D1A-6537-0383
person.identifier.ciencia-idA418-A85E-5DB1
person.identifier.ciencia-id281D-5E01-F09A
person.identifier.ciencia-id091C-0D58-7225
person.identifier.orcid0000-0003-2620-5760
person.identifier.orcid0000-0002-0329-4265
person.identifier.orcid0000-0003-0225-9537
person.identifier.orcid0000-0002-3878-6948
person.identifier.orcid0000-0002-2136-1396
person.identifier.ridE-2165-2012
person.identifier.ridH-1392-2017
person.identifier.scopus-author-id55125292100
person.identifier.scopus-author-id53986075100
person.identifier.scopus-author-id6507927018
person.identifier.scopus-author-id8607930100
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication90a94579-d2cb-47a7-8f9f-991b29dfa9d1
relation.isAuthorOfPublicationf7e806c8-708d-4caf-9b95-cfe9f3b06e8e
relation.isAuthorOfPublication0ca8c16f-6881-4662-bafc-cc51c5ce8d88
relation.isAuthorOfPublication5361e29a-3b79-4ce8-9f87-0c667d60588d
relation.isAuthorOfPublication1bd4d8f1-40e5-45af-b1e8-4b8e73a6a70d
relation.isAuthorOfPublication.latestForDiscoveryf7e806c8-708d-4caf-9b95-cfe9f3b06e8e
relation.isProjectOfPublication868b4818-3efa-4edb-9202-c464d64fd38f
relation.isProjectOfPublicatione13142f2-37b8-4b5a-b2cd-352e62003184
relation.isProjectOfPublication.latestForDiscoverye13142f2-37b8-4b5a-b2cd-352e62003184

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cunha et al. 2019.pdf
Size:
605.8 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.46 KB
Format:
Item-specific license agreed upon to submission
Description: